Review
doi: 10.1038/nm0496-392.
New pharmaceutical approaches to the treatment of cystic fibrosis
Affiliations
- PMID: 8597941
- DOI: 10.1038/nm0496-392
Item in Clipboard
Review
New pharmaceutical approaches to the treatment of cystic fibrosis
Nat Med.
1996 Apr.
No abstract available
Comment on
-
Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations.Nat Med. 1996 Apr;2(4):467-9. doi: 10.1038/nm0496-467. Nat Med. 1996. PMID: 8597960
Similar articles
-
Cystic fibrosis transmembrane conductance regulator biomarkers in 'real life': can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?Ther Adv Respir Dis. 2015 Aug;9(4):198-200. doi: 10.1177/1753465815579364. Ther Adv Respir Dis. 2015. PMID: 26175480 No abstract available.
-
Drug bests cystic-fibrosis mutation.Nature. 2012 Feb 7;482(7384):145. doi: 10.1038/482145a. Nature. 2012. PMID: 22318583 No abstract available.
-
Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.Paediatr Respir Rev. 2017 Mar;22:47-49. doi: 10.1016/j.prrv.2016.10.005. Epub 2016 Nov 5. Paediatr Respir Rev. 2017. PMID: 27964951 Review. No abstract available.
-
Pharmacological approaches to cystic fibrosis.Eur J Med Chem. 2021 Apr 15;216:113240. doi: 10.1016/j.ejmech.2021.113240. Epub 2021 Jan 30. Eur J Med Chem. 2021. PMID: 33691259 No abstract available.
-
delta F508 in cystic fibrosis: willing but not able.Arch Dis Child. 1997 Mar;76(3):278-82. doi: 10.1136/adc.76.3.278. Arch Dis Child. 1997. PMID: 9135274 Free PMC article. Review. No abstract available.
Cited by
-
Genetics and pulmonary medicine. 1. The genetics of cystic fibrosis lung disease.Thorax. 1998 May;53(5):389-97. doi: 10.1136/thx.53.5.389. Thorax. 1998. PMID: 9708232 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
